Depakote Birth Defect Injuries


Use of Depakote During Pregnancy May Result in Birth Defects


The prescription drug Depakote was developed and marketed to treat manic bipolar episodes and seizures. Since its introduction to the drug market in 1983, Depakote has been linked to the potential development of severe birth defects. In 2006, in response to mounting evidence of Depakote’s association with birth defect development, the FDA required a black-box warning be featured on the product packaging. This label was designed to bring attention to the risks posed by Depakote to women taking the drug during pregnancy. Unfortunately, this warning came too late for many women who had previously been prescribed and had used Depakote during their pregnancies.

The use of Depakote has been connected to a wide range of birth defects. Some of these birth defects involve: missing or extra toes and fingers, abnormal skull shapes, spina bifida, various heart defects and cleft palates. These defects can lead to life-long health consequences for children.

Kirkendall Dwyer LLP is currently reviewing potential claims for mothers and their children related to Depakote injuries.  If you used Depakote during pregnancy and your child was born with resulting birth injury, then please complete the form on this page or call 877-503-1595.  There is no cost to you for a case review.  We are only compensated if we recover money for you.  Click here to get started.

Science Suggests Birth Defects Linked to Use of Depakote


According to a 2010 European research publication, Depakote, when taken as early as the first trimester, increases the risk of birth defects.  Researchers found that taking Depakote resulted in a 12-fold increased risk of spina bifida, a 7-fold increased risk of craniosynostosis (abnormal skull), a five-fold increased risk of cleft palate, and 2.5 times the risk of the baby developing an atrial septal defect (a hole in the heart).

Kirkendall Dwyer LLP is reviewing cases involving the following birth defect injuries:

  • Spina Bifida
  • Arm or Leg Deformities
  • Head and Brain Malformation
  • Missing or Extra Fingers or Toes
  • Cleft Palate
  • Deformed Head or Face
  • Holes in the Heart Walls


Case Review of Depakote Birth Injury Claim

If you are interested in our attorneys reviewing your potential claim, then please click here to complete a contact form or call Kirkendall Dwyer LLP at 877-503-1595.



Blog Posts

ProPublica Offers Nine Ways to make Tylenol Safer

ProPublica, the investigative newsroom that has often discussed issues of drug safety and pharmaceutical company behavior, recently published an article entitled “Nine Ideas to Make Tylenol and Other Acetaminophen Drugs Safer”.  In the piece ProPublica journalists offer the following ideas to make the drug safer for public use and hopefully decrease the number of users…

Posted in Tylenol

Emails Show that Bard Knew of TVM Problems

Court records from this summer revealed that transvaginal mesh manufacturer Bard knew that they were manufacturing their mesh out of plastic that was not suitable for implantation in humans.  The medical device manufacturer had been told as much by the suppliers of the plastic resin, Chevron Phillips Chemical Company.  Chevron clearly warned Bard that the…

Posted in C.R. Bard, Transvaginal Mesh

Novo Nordisk Seeks New Uses for Victoza

Novo Nordisk’s Chief Science Officer Mads Krogsgaard Thomsen stated that the pharmaceutical company is looking into continuing trials to determine if Victoza could be marketed as a possible Alzheimer’s treatment.  Victoza is currently going through a proof of concept study.  If this is successful, the drug will continue through phase III clinical trials to see…

Posted in Actos, Dangerous Diabetes Drugs, Victoza